5.12 USD
↗ 0.09 (1.79%)AT CLOSE (11:59 AM EDT)
Insight Molecular Diagnostics Inc. Common Stock
IMDXNASDAQ • USD
5.10
↘ 0.03 (0.49%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
5.10
↘ 0.03 (0.49%)
Market: CLOSED
Insight Molecular Diagnostics Inc. Common Stock (IMDX) is currently trading at $5.12. IMDX shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (447.5%) and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 4, 2026.
Open?$5.11
High?$5.32
Low?$5.03
Prev. Close?$5.03
Volume?200.2K
Avg. Volume?185.3K
VWAP?$5.17
Rel. Volume?1.08x
Bid / Ask
Bid?$3.48 × 100
Ask?$5.89 × 100
Spread?$2.41
Midpoint?$4.69
Valuation & Ratios
Market Cap?162.4M
Shares Out?32.3M
Float?25.5M
Float %?78.9%
P/E Ratio?N/A
P/B Ratio?-15.19
EPS?-$1.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.
Employees
58
Market Cap
162.4M
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
Listed
2015-12-30
Address
2 INTERNATIONAL PLAZA DR., SUITE 510
NASHVILLE, TN 37217
Phone: 949-409-7600
NASHVILLE, TN 37217
Phone: 949-409-7600
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?39
Piotroski F-Score?0/9Weak
Altman Z-Score?-16.01Distress
Confidence?34%Very Low
Short InterestModerate
Short % of Float?4.89%Low
Short Interest?1.2M
Days to Cover?4.3
Free Float25.5M
Avg Daily Volume287.1K
Settlement Date2026-07-15
Financial Health
Current Ratio?2.48Strong
Quick Ratio?2.45Strong
Cash Ratio?2.35Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-15.19CHEAP▾
S&P97
P/S?83.33HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.6CHEAP▾
S&P97
EV/Sales?68.87HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?447.5%STRONG▾
Peers50
S&P97
ROA?-118.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-27456000
Enterprise Value?$134.2M
Fundamentals ratios updated end of day